Officer Paul Mahon Files Intent to Sell $4M in Shares, Continuing Recent Distribution Trend
UTHR sits 79% above its 52-week low of $266.98.
Summary
Officer Paul Mahon filed a Form 144 to sell 8,300 shares worth approximately $4.01 million, extending a trend of significant share dispositions totaling over $33 million in the last three months.
Key Events · Ownership and Investor Activity · UTHR
-
Officer Files Intent to Sell
Officer Paul Mahon has filed a Form 144 indicating an intent to sell 8,300 shares of common stock.
-
Proposed Sale Value
The approximate market value of the shares intended for sale is $4,010,939.31.
-
Continuation of Recent Sales
This proposed sale follows a pattern of dispositions by the same officer, who has sold a total of 60,600 shares with gross proceeds of $29,364,503.43 in the past three months, bringing total sales (proposed + recent) to over $33 million.
-
Nature of Acquisition
The shares to be sold were acquired through a stock option exercise.
Analysis · UTHR · Life Sciences
This Form 144 indicates that Officer Paul Mahon intends to sell an additional 8,300 shares, valued at approximately $4.01 million. This proposed sale is part of a larger pattern, as Mahon has sold over $33 million worth of shares in the past three months. While the current proposed sale is a modest percentage of the company's market capitalization, the consistent and significant volume of sales by a key officer suggests a continued reduction in personal holdings, often associated with liquidity or diversification rather than a direct negative signal about the company's fundamentals. Investors should note the ongoing distribution by this insider.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 30.5% of the 1993 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.21%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UTHR was trading at $478.93 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.6B. The 52-week trading range was $266.98 to $519.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.